TrialWiener klinische Wochenschrift2014
Differences of frequency in administration of ranibizumab and bevacizumab in patients with neovascular AMD.
Andreas Scholler et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it